Study of the No-touch Saphenous Vein Graft
Coronary Artery Disease, Coronary Artery Stenosis, Graft Failure
About this trial
This is an interventional treatment trial for Coronary Artery Disease focused on measuring no-touch saphenous vein graft; CABG
Eligibility Criteria
Inclusion Criteria: Patients with coronary artery disease requiring three-vessel myocardial revascularization Patient consent to the study Exclusion Criteria: The diameter of the target arteries for conduits of the internal mammary arteries is less than 1 mm Hemodynamically significant atherosclerosis of the subclavian arteries in the first segment Stenosis of the right coronary artery less than 90% Concomitant pathology requiring additional simultaneous surgical correction Lack of HAV COPD with FEV1 <60% BMI >35 Prior heart surgery Oncological diseases with a life expectancy of less than 5 years ACS CKD stage 4 and higher The diameter of the SVG is less than 2 mm or its varicose expansion is more than 6 mm CLTI IIb and more.
Sites / Locations
- NMCR named after academician E.N. Meshalkin of the Ministry of Health of rhe RussianRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
"no-touch" saphenous vein as I-graft
"no-touch" saphenous vein as conventional free graft
Coronary bypass surgery according to the I-graft method. Proximal anastomosis to RIMA.
Coronary artery bypass grafting using the free conduit technique. Proximal anastomosis to aorta.